EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cryoablation of atrial fibrillation in “very severe” obese patients (BMI ≥ 40): Indications, feasibility, procedural safety and efficacy, and clinical outcome (the ICE‐Obese Extreme)

Lukas Urbanek iD, Boris Schmidt iD, Stefano Bordignon iD, David Schaack, Ramin Ebrahimi, Shota Tohoku, Jun Hirokami iD, Tolga Han Efe, Karin Plank iD, Britta Schulte-Hahn, Bernd Nowak, Julian K R Chun und 1 weitere

Journal of Cardiovascular Electrophysiology · 2024

DOI: 10.1111/jce.16302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Lukas Urbanek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardioangiologisches Centrum Bethanien (CCB), Kardiologie, Medizinische Klinik III, Agaplesion Markus Krankenhaus, Akademisches Lehrkrankenhaus der G…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cryosurgery, Feasibility Studies, Body Mass Index. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Management of atrial fibrillation (AF) in very severe obese patients is challenging. Cryoballoon ablation (CBA) represents an effective rhythm control strategy. However, data in this patient group were limited.

Methods

Highly symptomatic AF patients with body mass index (BMI) ≥ 40 kg/m 2 who had failed antiarrhythmic drug therapy and electrocardioversion and failure to achieve targeted body‐weight‐reduction underwent CBA.

Results

Data of 72 very severe obese AF patients (Group A) and 129 AF patients with normal BMI (Group B, BMI < 25 kg/m 2 ) were consecutively collected. Group A had significantly younger age (60.6 ± 10.4 vs. 69.2 ± 11.2 years), higher BMI (44.3 ± 4.3 vs. 22.5 ± 1.6 kg/m 2 ). Procedural pulmonary vein isolation (PVI) was successful in all patients (2 touch‐up ablation in Group A). Compared to Group B, Group A had similar procedural (61.3 ± 22.6 vs. 57.5 ± 19 min), similar fluoroscopy time (10.1 ± 5.5 vs. 9.2 ± 4.8 min) but significantly higher radiation dose (2852 ± 2095 vs. 884 ± 732 µGym 2 ). We observed similar rates of real‐time‐isolation (78.6% vs. 78.5%), single‐shot‐isolation (86.5% vs. 88.8%), but significantly longer time‐to‐sustained‐isolation (53.5 ± 33 vs. 43.2 ± 25 s). There was significantly higher rate of puncture‐site‐complication (6.9% vs. 1.6%) in Group A. One‐year clinical success in paroxysmal AF was (Group A: 69.4% vs. Group B: 80.2%; p < .001), in persistent AF was (Group A: 58.1% vs. Group B: 62.8%; p = .889). In Re‐Do procedures Group A had a numerically lower PVI durability (75.0% vs. 83.6%, p = .089).

Conclusion

For very severe obese AF patients, CBA appears feasible, leads to relatively good clinical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCryosurgeryFeasibility StudiesBody Mass IndexObesityPulmonary VeinsHumansMaleFemaleTreatment OutcomeMiddle AgedAgedRisk FactorsTime FactorsHeart RateSeverity of Illness IndexAction PotentialsRetrospective StudiesRecurrence

Stichwörter der Autor:innen

BMIatrial fibrillationcryoablationcryoballoonobesitypulmonary vein isolation

Autor:innen und Institutionen

  • Cardioangiologisches Centrum Bethanien (CCB), Kardiologie, Medizinische Klinik III, Agaplesion Markus Krankenhaus, Akademisches Lehrkrankenhaus der Goethe-Universität, Frankfurt am Main, Germany.
  • Die Sektion Medizin, Universität zu Lübeck, Lübeck, Germany.
  • Section of Rhythmology/Electrophysiology, Department of Internal Medicine B (Kardiologie, Angiologie, Pneumologie/Infektiologie und internistische Intensivmedizin), University Medicine Greifswald, Ferdinand-Sauerbruch-S…

ORCID-Profile: Lukas Urbanek, Boris Schmidt, Stefano Bordignon, Jun Hirokami, Karin Plank, Shaojie Chen

Zitieren

APA

Urbanek, L., Schmidt, B., Bordignon, S., Schaack, D., Ebrahimi, R., Tohoku, S., Hirokami, J., Efe, T. H., Plank, K., Schulte-Hahn, B., Nowak, B., Chun, J. K. R., & Chen, S. (2024). Cryoablation of atrial fibrillation in “very severe” obese patients (BMI ≥ 40): Indications, feasibility, procedural safety and efficacy, and clinical outcome (the ICE‐Obese Extreme). Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16302

Vancouver

Urbanek L, Schmidt B, Bordignon S, Schaack D, Ebrahimi R, Tohoku S, et al. Cryoablation of atrial fibrillation in “very severe” obese patients (BMI ≥ 40): Indications, feasibility, procedural safety and efficacy, and clinical outcome (the ICE‐Obese Extreme). Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16302

BibTeX
@article{Urbanek2024,
  author = {Urbanek, Lukas and Schmidt, Boris and Bordignon, Stefano and Schaack, David and Ebrahimi, Ramin and Tohoku, Shota and Hirokami, Jun and Efe, Tolga Han and Plank, Karin and Schulte-Hahn, Britta and Nowak, Bernd and Chun, Julian K R and Chen, Shaojie},
  title = {Cryoablation of atrial fibrillation in “very severe” obese patients (BMI ≥ 40): Indications, feasibility, procedural safety and efficacy, and clinical outcome (the ICE‐Obese Extreme)},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  doi = {10.1111/jce.16302}
}
Kostenlos starten →